{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:54:34Z","timestamp":1791644074196,"version":"4.3.4"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":2500,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,26]],"date-time":"2016-01-26T00:00:00Z","timestamp":1453766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Male Reproductive Health Research Career Development","award":["HD073917-01"],"award-info":[{"award-number":["HD073917-01"]}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["smoa.jsexmed.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Male orgasmic disorder is common, with few treatment options. Cabergoline is a dopamine agonist that acts centrally to normalize serum prolactin that could improve orgasmic dysfunction.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>To determine whether cabergoline increases the potential for orgasm in men with orgasmic disorder.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A retrospective chart review of men treated in a single andrology clinic for delayed orgasm or anorgasmia in a pilot study using cabergoline 0.5 mg twice weekly was performed. Duration of treatment and response were noted. Medical records were examined for other factors including history of prostatectomy and concomitant androgen supplementation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>Subjective improvement in orgasmic function resulting from cabergoline treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 131 men treated with cabergoline for orgasmic disorder, 87 (66.4%) reported subjective improvement in orgasm and 44 (33.6%) reported no change in orgasm. Duration of therapy (P\u00a0= .03) and concomitant testosterone therapy (P\u00a0= .02) were associated with a significant positive response to cabergoline treatment. No differences were found between injectable and non-injectable testosterone formulations (P\u00a0= .90), and neither age (P\u00a0= .90) nor prior prostatectomy (P\u00a0= .41) influenced the outcome of cabergoline treatment. Serum testosterone levels before (P\u00a0= .26) and after (P\u00a0= .81) treatment were not significantly different in responders vs non-responders.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Cabergoline is a potentially effective and easy-to-administer treatment for male orgasmic disorder, the efficacy of which appears to be independent of patient age or orgasmic disorder etiology. Prospective randomized trials are needed to determine the true role of cabergoline in the treatment of this disorder.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1016\/j.esxm.2015.09.001","type":"journal-article","created":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T03:17:20Z","timestamp":1456888640000},"page":"e28-e33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Cabergoline in the Treatment of Male Orgasmic Disorder\u2014A Retrospective Pilot Analysis"],"prefix":"10.1093","volume":"4","author":[{"given":"Adam B.","family":"Hollander","sequence":"first","affiliation":[{"name":"Scott Department of Urology , Houston, TX, \u00a0 USA"},{"name":"Baylor College of Medicine , Houston, TX, \u00a0 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander W.","family":"Pastuszak","sequence":"additional","affiliation":[{"name":"Scott Department of Urology , Houston, TX, \u00a0 USA"},{"name":"Baylor College of Medicine , Houston, TX, \u00a0 USA"},{"name":"Center for Reproductive Medicine , Houston, TX, \u00a0 USA"},{"name":"Baylor College of Medicine , Houston, TX, \u00a0 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tung-Chin","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Department of Urology , San Diego, CA, \u00a0 USA"},{"name":"University of California\u2013San Diego , San Diego, CA, \u00a0 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Scott Department of Urology , Houston, TX, \u00a0 USA"},{"name":"Baylor College of Medicine , Houston, TX, \u00a0 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Scovell","sequence":"additional","affiliation":[{"name":"Scott Department of Urology , Houston, TX, \u00a0 USA"},{"name":"Baylor College of Medicine , Houston, TX, \u00a0 USA"},{"name":"Center for Reproductive Medicine , Houston, TX, \u00a0 USA"},{"name":"Baylor College of Medicine , Houston, TX, \u00a0 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina K.","family":"Mai","sequence":"additional","affiliation":[{"name":"Scott Department of Urology , Houston, TX, \u00a0 USA"},{"name":"Baylor College of Medicine , Houston, TX, \u00a0 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry I.","family":"Lipshultz","sequence":"additional","affiliation":[{"name":"Scott Department of Urology , Houston, TX, \u00a0 USA"},{"name":"Baylor College of Medicine , Houston, TX, \u00a0 USA"},{"name":"Center for Reproductive Medicine , Houston, TX, \u00a0 USA"},{"name":"Baylor College of Medicine , Houston, TX, \u00a0 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,3,1]]},"reference":[{"key":"2023011904395209000_bib1","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1176\/foc.3.4.520","article-title":"Sexual dysfunction","volume":"3","author":"IsHak","year":"2005","journal-title":"Focus"},{"key":"2023011904395209000_bib2","first-page":"1022","article-title":"Male anorgasmia treated with oxytocin","volume":"5","author":"IsHak","year":"2008","journal-title":"J\u00a0Sex Med"},{"key":"2023011904395209000_bib3","first-page":"204","article-title":"Standard operating procedures in the disorders of orgasm and ejaculation","volume":"10","author":"McMahon","year":"2013","journal-title":"J\u00a0Sex Med"},{"key":"2023011904395209000_bib4","first-page":"1668","article-title":"Disorders of orgasm and ejaculation in men","volume":"7","author":"Rowland","year":"2010","journal-title":"J\u00a0Sex Med"},{"key":"2023011904395209000_bib5","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nrurol.2012.147","article-title":"The hormonal control of ejaculation","volume":"9","author":"Corona","year":"2012","journal-title":"Nat Rev Urol"},{"key":"2023011904395209000_bib6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/ijir.2011.8","article-title":"Erectile dysfunction and sexual health after radical prostatectomy: impact of sexual motivation","volume":"23","author":"Messaoudi","year":"2011","journal-title":"Int J Impot Res"},{"key":"2023011904395209000_bib7","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1464-410X.2004.05009.x","article-title":"The prevalence and nature of orgasmic dysfunction after radical prostatectomy","volume":"94","author":"Barnas","year":"2004","journal-title":"BJU Int"},{"key":"2023011904395209000_bib8","first-page":"279","article-title":"Prostate cancer: perspectives on quality of life and impact of treatment on patients and their partners","volume":"23","author":"Crowe","year":"2003","journal-title":"Urol Nurs"},{"key":"2023011904395209000_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2605.2010.01059.x","article-title":"Premature and delayed ejaculation: two ends of a single continuum influenced by hormonal milieu","volume":"34","author":"Corona","year":"2011","journal-title":"Int J Androl"},{"key":"2023011904395209000_bib10","first-page":"240","article-title":"Low prolactin is associated with sexual dysfunction and psychological or metabolic disturbances in middle-aged and elderly men: the European Male Aging Study (EMAS)","volume":"11","author":"Corona","year":"2014","journal-title":"J\u00a0Sex Med"},{"key":"2023011904395209000_bib11","first-page":"1457","article-title":"Hypoprolactinemia: a new clinical syndrome in patients with sexual dysfunction","volume":"6","author":"Corona","year":"2009","journal-title":"J\u00a0Sex Med"},{"key":"2023011904395209000_bib12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/sj.ijir.3900823","article-title":"Absence of orgasm-induced prolactin secretion in a healthy multi-orgasmic male subject","volume":"14","author":"Haake","year":"2002","journal-title":"Int J Impot Res"},{"key":"2023011904395209000_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0149-7634(01)00036-7","article-title":"Orgasm-induced prolactin secretion: feedback control of sexual drive?","volume":"26","author":"Kruger","year":"2002","journal-title":"Neurosci Biobehav Rev"},{"key":"2023011904395209000_bib14","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/sj.ijir.3901483","article-title":"Cabergoline treatment in men with psychogenic erectile dysfunction: a randomized, double-blind, placebo-controlled study","volume":"19","author":"Nickel","year":"2007","journal-title":"Int J Impot Res"},{"key":"2023011904395209000_bib15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1677\/joe.0.1790357","article-title":"Effects of acute prolactin manipulation on sexual drive and function in males","volume":"179","author":"Kruger","year":"2003","journal-title":"J\u00a0Endocrinol"},{"key":"2023011904395209000_bib16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1210\/jc.2003-030852","article-title":"Six months of treatment with cabergoline restores sexual potency in hyperprolactinemic males: an open longitudinal study monitoring nocturnal penile tumescence","volume":"89","author":"De Rosa","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"2023011904395209000_bib17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0306-4530(99)00049-9","article-title":"Neuroendocrine response to film-induced sexual arousal in men and women","volume":"25","author":"Exton","year":"2000","journal-title":"Psychoneuroendocrinology"},{"key":"2023011904395209000_bib18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0306-4530(00)00053-6","article-title":"Coitus-induced orgasm stimulates prolactin secretion in healthy subjects","volume":"26","author":"Exton","year":"2001","journal-title":"Psychoneuroendocrinology"},{"key":"2023011904395209000_bib19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s003450100222","article-title":"Endocrine response to masturbation-induced orgasm in healthy men following a 3-week sexual abstinence","volume":"19","author":"Exton","year":"2001","journal-title":"World J Urol"},{"key":"2023011904395209000_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1210\/jcem-64-1-27","article-title":"Plasma oxytocin increases in the human sexual response","volume":"64","author":"Carmichael","year":"1987","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"2023011904395209000_bib21","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1212\/WNL.58.5.831","article-title":"Cabergoline can increase penile erections and libido","volume":"58","author":"Wittstock","year":"2002","journal-title":"Neurology"},{"key":"2023011904395209000_bib22","first-page":"1074","article-title":"Risk factors associated with primary and secondary reduced libido in male patients with sexual dysfunction","volume":"10","author":"Corona","year":"2013","journal-title":"J\u00a0Sex Med"}],"container-title":["Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050116116000076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050116116000076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/smoa\/article-pdf\/4\/1\/e28\/48762425\/smoa_4_1_e28.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/smoa\/article-pdf\/4\/1\/e28\/48762425\/smoa_4_1_e28.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T04:44:49Z","timestamp":1674103489000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/smoa\/article\/4\/1\/e28\/6956244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,3,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.esxm.2015.09.001","relation":{},"ISSN":["2050-1161"],"issn-type":[{"value":"2050-1161","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,3]]},"published":{"date-parts":[[2016,3,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cabergoline in the Treatment of Male Orgasmic Disorder\u2014A Retrospective Pilot Analysis","name":"articletitle","label":"Article Title"},{"value":"Sexual Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esxm.2015.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}